Form 4: Trilogy Metals Director Exercises Options, Sells Shares

Sentiment:

Insider Transaction Report 10 October 2025 6:55 PM

A director at Trilogy Metals Inc. exercised stock options and subsequently sold a portion of the acquired common shares in early October 2025.

Summary

William Beckwith Hayden, a Director of Trilogy Metals Inc., engaged in multiple equity transactions on October 8 and October 9, 2025.
On October 8, 2025, Hayden exercised stock options to acquire a total of 325,000 common shares at exercise prices ranging from $0.42 to $1.81 per share. These prices were converted from Canadian dollar exercise prices using an exchange rate of C$1.3952 = US$1.00.
Specifically, 100,000 shares were acquired at $1.81, 50,000 shares at $1.58, 50,000 shares at $0.56, 50,000 shares at $0.42, and 75,000 shares at $1.09.
Following these acquisitions, Hayden's direct beneficial ownership increased to 647,159 common shares before subsequent sales.
Also on October 8, 2025, Hayden sold 64,294 common shares at a weighted average price of $7.06 per share (converted from C$9.85769, with sales ranging from C$9.70 to C$10.04).
On October 9, 2025, Hayden sold an additional 200,000 common shares at a weighted average price of $6.61 per share (converted from C$9.2554, with sales ranging from C$9.102 to C$9.38).
After all reported transactions, Hayden's direct beneficial ownership stands at 382,685 common shares.
All derivative securities related to these exercises are now beneficially owned at 0.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the director both exercised options (positive, indicating value) and sold a significant portion of shares (potentially negative, indicating profit-taking or reduced exposure). The net effect on beneficial ownership is a decrease.

Positives

The director exercised a substantial number of stock options (325,000 shares), indicating a belief in the value of the company's equity at the time of option grant.
The sale prices ($7.06 and $6.61) are significantly higher than the exercise prices (ranging from $0.42 to $1.81), demonstrating a profitable transaction for the director.

Negatives

A director sold a total of 264,294 common shares over two days, which represents a reduction in their direct equity exposure to the company.
The total number of shares beneficially owned by the director decreased from 647,159 (after exercises) to 382,685 (after sales), a net reduction of 264,474 shares from the peak during the transaction period.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance.

Industry Context

This filing reports an insider transaction, which is a routine disclosure for publicly traded companies. It does not provide broader industry context or trends.

Stakeholder Impact

Shareholders may interpret the director's sale as a signal, potentially influencing market sentiment regarding the company's stock.

Key Dates

Date	Description
12/10/2020	Date exercisable for 100,000 common shares with an exercise price of $1.81.
12/09/2021	Date exercisable for 50,000 common shares with an exercise price of $1.58.
12/08/2022	Date exercisable for 50,000 common shares with an exercise price of $0.56.
12/07/2023	Date exercisable for 50,000 common shares with an exercise price of $0.42.
12/09/2024	Date exercisable for 75,000 common shares with an exercise price of $1.09.
10/08/2025	Date of multiple option exercises and a sale of 64,294 common shares.
10/09/2025	Date of sale of 200,000 common shares.
10/10/2025	Date the Form 4 was signed and filed.
12/09/2025	Expiration date for 100,000 common shares with an exercise price of $1.81.
12/08/2026	Expiration date for 50,000 common shares with an exercise price of $1.58.
12/07/2027	Expiration date for 50,000 common shares with an exercise price of $0.56.
12/06/2028	Expiration date for 50,000 common shares with an exercise price of $0.42.
12/09/2029	Expiration date for 75,000 common shares with an exercise price of $1.09.

Recommendation

hold

The director's exercise of options indicates a belief in the underlying value of the options, but the subsequent sale of a significant portion of shares could be interpreted as profit-taking or a reduction in personal exposure. Without further context on the director's overall holdings or company performance, a 'hold' recommendation is prudent as the signals are mixed.

Keywords

Trilogy Metals Inc., TMQ, Form 4, Insider Trading, Stock Options, Share Sale, Director Transactions, Equity, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.